Analysis of Bioprosthetic Aortic Valve Thrombosis-Implications and Management Strategies.
TAVI
TAVR
aortic stenosis
bioprosthesis
thrombosis
Journal
Journal of cardiothoracic and vascular anesthesia
ISSN: 1532-8422
Titre abrégé: J Cardiothorac Vasc Anesth
Pays: United States
ID NLM: 9110208
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
received:
15
10
2018
pubmed:
21
11
2018
medline:
23
6
2020
entrez:
21
11
2018
Statut:
ppublish
Résumé
Aortic valve disease is a common condition whose prevalence is increasing, especially in Western countries. Two main families of cardiac prostheses are available: mechanical and biological prostheses. Nevertheless, the use of mechanical surgical valves has declined significantly over time in favor of bioprosthetic surgical valves even among middle-aged patients. The dominance of bioprosthetic valves was enhanced further with the introduction of transcatheter aortic valves. However, some concerns have arisen in recent years about clinical and subclinical leaflet thrombosis of both surgical and transcatheter bioprostheses. This manuscript aims to discuss the current evidence relating to the incidence, pathophysiology, clinical implications, and management strategies of biological valve leaflet thrombosis.
Identifiants
pubmed: 30455145
pii: S1053-0770(18)30951-0
doi: 10.1053/j.jvca.2018.10.025
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2853-2860Informations de copyright
Copyright © 2018 Elsevier Inc. All rights reserved.